Safety and Efficacy of Simeprevir/Sofosbuvir in Hepatitis C Infected Patients with Compensated and Decompensated Cirrhosis

BACKGROUND/AIMS: Risks and benefits of simeprevir plus sofosbuvir in patients with advanced cirrhosis are unknown. We assessed the safety and sustained virologic responses (SVR) of simeprevir plus sofosbuvir with and without ribavirin in patients with Child-Pugh (CP)-B/C vs. CP-A cirrhosis and compa...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hepatology
Main Authors: Saxena, Varun, Nyberg, Lisa, Pauly, Marypat, Dasgupta, Aditi, Nyberg, Anders, Piasecki, Barbara, Winston, Bradley, Redd, Jacquelyn, Ready, Joanna, Terrault, Norah
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4549204/
https://ncbi.nlm.nih.gov/pubmed/26033798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.27922
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados